Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.25 -0.25 (-7.14%)
As of: Oct 20, 2026 · 3:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Notes Payables (2023 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) reported Notes Payables of $8.91 million for Q2 2026.

Analysis

Apimeds Pharmaceuticals US (APUS) Notes Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US posted Notes Payables of $7.09 million.

  • By year, Notes Payables came in at $250,000 in FY2024 (-6.3%) and $266,891 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.91 Mn
Dec 31, 2025 7.09 Mn
Mar 31, 2025 373,620.00
Dec 31, 2024 250,000.00
Dec 31, 2023 266,891.00
API Access

Apimeds Pharmaceuticals US Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=APUS&period=max&api_key=YOUR_API_KEY